The pair will expand Abridge's generative AI clinical documentation platform across the health system’s providers after a successful pilot.

The acquisition joins SeqOne's platform for sequencing analysis with Congenica's clinical decision support technology.

The technique could give patients a way to detect signs of the disease and get help in early stages.

The company will use the funds to expand access to its AI-driven platform that allows providers to access and organize patient medical records.

Matt Koehler, VP of product innovation at Surescripts, describes a scenario, which was presented at AHIP 2025, where prior auth can be completed in 30 seconds using coordination between the physician, PBM and EHR.

The company gives patients with chronic diseases access to tools that help them monitor their heart rate and blood pressure.